Update regarding offer on FRISQ’s operating subsidiaries

As previously announced, The Board of Directors (“Board”) of FRISQ Holding AB (publ) ("FRISQ" or "the Company") has received a non-binding offer for the Company's operating subsidiaries FRISQ AB, FRISQ UK LTD and FRISQ USA Holding Inc (together the "Subsidiaries") for a total purchase price of approximately SEK 106 million. The offer has been submitted by Kerdos Capital Ventures Ltd ("Kerdos"). As a result hereof, the Board has convened an Extraordinary General Meeting to be held on February 8 at 15.00 to vote about the divestment of the Subsidiaries. Kerdos has requested additional time to complete the documents required for the transaction and the Board therefore intends to propose at the Extraordinary General Meeting that the meeting should continue at a later date. The new date for the continued Extraordinary General Meeting will be announced as soon as possible.

About FRISQ:

FRISQ is a healthtech company built on the conviction that the quality of the care you get should not be dependent on your ability to navigate a complex system and constantly evolving treatments. The software solution FRISQ Care enables the creation of personalized, digital care plans that facilitate collaboration and secure information sharing between care teams, doctors and patients through the same platform.

Since 2016, FRISQ has been listed on Nasdaq First North Stockholm under the symbol “FRISQ”. FNCA Sweden AB is FRISQ’s Certified Adviser and can be reached via the following contact information: +46 8 528 00 399, info@fnca.se

The publication is a translation of the original Swedish text. In the event of inconsistency or discrepancy between the Swedish version and this publication, the Swedish language version shall prevail.

For more information, please visit: www.frisqholding.se

Update regarding offer on FRISQ’s operating subsidiaries

MENY